Page last updated: 2024-11-01

nialamide and Glaucoma

nialamide has been researched along with Glaucoma in 2 studies

Nialamide: An MAO inhibitor that is used as an antidepressive agent.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
YAMAMOTO, Y1
HIKAWA, T1
KATO, M1
KITSUKAWA, H1
MONTIBERT, M1

Other Studies

2 other studies available for nialamide and Glaucoma

ArticleYear
[EFFECT OF NIAMID IN OPHTHALMOLOGY].
    Rinsho ganka. Japanese journal of clinical ophthalmology, 1963, Volume: 17

    Topics: Adolescent; Asthenopia; Cataract; Geriatrics; Glaucoma; Neurotic Disorders; Nialamide; Ophthalmology

1963
[EMPLOYMENT OF NIAMID IN OPHTHALMOLOGY].
    Lyon medical, 1964, Nov-01, Volume: 212

    Topics: Biomedical Research; Cataract Extraction; Drug Therapy; Employment; Geriatrics; Glaucoma; Humans; Ni

1964